Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

Today's health news includes what RFK Jr. can do on vaccines, escaped monkeys, and who know in the Make America Healthy Again ...

One dose of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) mpox vaccine was moderately effective in preventing mpox infections, according to a Canadian observational, emulated ...

The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved in several countries for the prevention of mpox and smallpox in adults, but insufficient data are available to support ...

Both organizations have made concerted efforts to help countries acquire vaccines amid ongoing outbreaks. WHO added the ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

Kenya is among nine countries in Africa that have been allocated MPOX vaccine doses, following an MPOX surge in the continent ...

There are two vaccines approved against mpox, MVA-BN and LC16. These jabs are based on weakened versions of orthopoxviral and ...

The announcement came on the heels of the arrival of the first MVA-BN vaccines to the Democratic Republic of Congo (DRC), the epicentre of the epidemic. "This first prequalification of a vaccine ...

Regardless of 1 or 2 doses, mpox antibodies wane by 6 to 12 months. HealthDay News — Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic ...

The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved in several countries for the prevention of mpox and smallpox in adults, but insufficient data are available to support ...

Clinical study in children 2-11 years of age follows the recent EMA and WHO approvals of the MVA-BN mpox vaccine for adolescents 12-17 of age. COPENHAGEN, Denmark, October 29, 2024 – Bavarian ...